The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes
Open accessAbstract
Children's Hospital Medical Center/Harvard Medical School, Boston, MA 021 15,' Institut fur Humangenetik und Genetische Poliklinik der Philipps-Universitat Marburg, Bahnhofstrasse 7A, West Germany,' Gladstone Foundation Laboratories, San Francisco, CA 94 140; Cardiovascular Research Institute, University of California, San Francisco, CA 941 43; Health Science Center, University of Texas, Dallas, T X 74235,5 Lipid Research Center, Washington University School of Medicine, St. Louis, M O 63110; Harborview Medical Center, Seattle, WA 98104; and Columbia College of Physicians and Surgeons, New York, NY 10032*
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The two genotypes combine into six common APOE genotypes, ε22, ε32, ε42, ε33, ε43 and ε44, corresponding to six plasma apoE phenotypes: apoE22, apoE32, apoE42, apoE33, apoE43 and apoE44 [14].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [14]
In the citing paper
“There are three common APOE alleles in the general population defined as: APOE ɛ2, APOE ɛ3, and APOE ɛ4 [2].”
From Discovery of a Missense Mutation (Q222K) of the APOE Gene from the Australian Imaging, Biomarker and Lifestyle Study (2023) · cites this paper as [2]
In the citing paper
“Apolipoprotein E (apoE) is one of the key apolipoproteins in blood lipid transport.”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
Citations
Cites
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Self-citationPolymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Self-citationZannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Self-citationWindler, E. E. T., Kovanen, P. T., Chao, Y. S., Brown, M. S., Havel, R. J., & Goldstein, J. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70487-6 · Cited by 456
Self-citationInnerarity, T. L., & Mahley, R. W. (1978) · Biochemistry · doi:10.1021/bi00601a013 · Cited by 433
Self-citationSherrill, B. C., Innerarity, T. L., & Mahley, R. W. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85951-3 · Cited by 426
Self-citationDeterminants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat.
Windler, E. E. T., Chao, Y. S., & Havel, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70811-4 · Cited by 365
Self-citationWindler, E., Chao, Y., & Havel, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70647-4 · Cited by 365
Self-citationEffect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.
Shelburne, F. A., Hanks, J., Meyers, W., & Quarfordt, S. H. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109710 · Cited by 358
(1981) · PubMed · Cited by 341
Self-citation
Research works printed but not linked: 2
- Utermann, G., A. Steinmetz, and W. Weber. 1982. Polymorphism of human apolipoprotein E: genetic control and gene frequencies. Am. J. Hum. Genet. In press.
- Sherrill, 1980, Addition of E-apoprotein to cholesterol-rich fluorescent lipid dispersion increases liver recognition and uptake, Circulation., 62, 44
Cited by
Sorted by citations
Items 201–300 of 435
Mella, J. G., Schirin-Sokhan, R., Rigotti, A., Pimentel, F., Villarroel, L. A., Wasmuth, H. E., Sauerbruch, T., Nervi, F. O., Lammert, F., & Miquel, J. F. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700059-jlr200 · Cited by 25
Molecular Genetics of Alzheimer's Disease
Verdile, G., & Martin, R. (2008) · Nucleic acids and molecular biology · doi:10.1007/978-3-540-85383-1_8 · Cited by 25
Georgiadou, D., Chroni, A., Vezeridis, A., Zannis, V. I., & Stratikos, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027037 · Cited by 24
Self-citationIdentification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes
Fan, J., Zareyan, S., Zhao, W., Shimizu, Y., Pfeifer, T. A., Tak, J., Isman, M. B., den Hoven, B. G. V., Duggan, M. E., Wood, M. W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162384 · Cited by 24
Apolipoprotein E Signals via TLR4 to Induce CXCL5 Secretion by Asthmatic Airway Epithelial Cells
Kalchiem‐Dekel, O., Yao, X., Barochia, A. V., Kaler, M. M., Figueroa, D. M., Karkowsky, W., Gordon, E. M., Gao, M., Fergusson, M. M., Qu, X., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0209oc · Cited by 24
Genetic Polymorphisms and Oxidative Stress in Heart Failure
Alameddine, F. M. F., & Zafari, A. M. (2002) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00719.x · Cited by 24
Barbagallo, C. M., Polizzi, F., Severino, M., Rizzo, M., Vivona, N., Onorato, F., Caldarella, R., Cefalu, A. B., Noto, D., Notarbartolo, A., et al. (2001) · European Journal of Epidemiology · doi:10.1023/a:1015618216828 · Cited by 24
Apolipoproteins, the Lipid Hypothesis, and Ischemic Heart Disease
Avogaro, P. (1985) · Springer eBooks · doi:10.1007/978-1-4684-7929-4_4 · Cited by 24
Chroni, A., Pyrpassopoulos, S., Thanassoulas, A., Nounesis, G., Zannis, V. I., & Stratikos, E. (2008) · Biochemistry · doi:10.1021/bi800469r · Cited by 26
Self-citationBeneš, P., Mužı́k, J., Benedı́k, J., Frélich, M., Elbl, L., Vašků, A., Znojil, V., & Vácha, J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2957 · Cited by 23
Zannis, V. I., Nicolosi, R. J., Jensen, E., Breslow, J. L., & Hayes, K. C. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34247-4 · Cited by 23
Self-citationDong, L.-M., Yamamura, T., & Yamamoto, A. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92336-x · Cited by 23
St‐Amand, J., Moorjani, S., Lupien, P. J., Prud’homme, D., & Després, J. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90064-5 · Cited by 23
Wardell, M. R., Rall, S., Brennan, S., Nye, E., George, P., Janus, E., & Weisgraber, K. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43175-x · Cited by 28
Self-citationMoorjani, S., Gaudet, D., Laberge, C. M., Thibault, M. C., Mathieu, J., Morissette, J., Lupien, P. J., Brun, D., & Gagné, C. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100028675 · Cited by 22
Apolipoprotein E Polymorphism and Brain Morphology in Mild Cognitive Impairment
Thomann, P. A., Roth, A.-S., Santos, V. D., Toro, P., Essig, M., & Schröder, J. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161054 · Cited by 22
Zhou, X., Fu, A. K. Y., & Ip, N. Y. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.02.001 · Cited by 23
Yılmaz, H., İşbir, T., Ağaçhan, B., & Aydın, M. (2001) · Cell Biochemistry and Function · doi:10.1002/cbf.915 · Cited by 22
Investigation of completed suicide and genes involved in cholesterol metabolism
Lalovic, A., Sequeira, A., DeGuzman, R., Chawky, N., LESAGE, A. D., Séguin, M., & Turecki, G. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00453-6 · Cited by 22
Dunn, F. L., Grundy, S. M., Bilheimer, D. W., Havel, R. J., & Raskin, P. (1985) · Metabolism · doi:10.1016/0026-0495(85)90220-3 · Cited by 22
Self-citationPro-inflammatory Cytokines Modulate Glial Apolipoprotein E Secretion
Poirier, J., Aleong, R., & Blain, J. (2008) · Current Alzheimer Research · doi:10.2174/156720508783884666 · Cited by 21
Panza, F., Seripa, D., D’Onofrio, G., Frisardi, V., Solfrizzi, V., Mecocci, P., & Pilotto, A. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/721457 · Cited by 22
Frequencies of apolipoproteins E5 and E7 in apparently healthy Japanese
Tsuchiya, S., Yamanouchi, Y., Onuki, M., Yamakawa, K., Miyazaki, R., Taya, T., Kondo, I., Ohnuki, M., & Hamaguchi, H. (1985) · The Japanese Journal of Human Genetics · doi:10.1007/bf01907964 · Cited by 21
Quantitative assessment of apolipoprotein E genotypes by image analysis of PCR–RFLP fragments
Wu, Y., Delgado, R., Costello, R., Sunderland, T., Dukoff, R. A., & Csákó, G. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00237-5 · Cited by 20
Apolipoprotein-E2 and Hyperlipoproteinemia in Noninsulin-Dependent Diabetes Mellitus*
Eto, M., Watanabe, K., Sato, T., & Makino, I. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1207 · Cited by 20
Barbagallo, C. M., Rizzo, M., Noto, D., Frasheri, A., Pernice, V., Rubino, A., Pieri, D., Pinto, V., Cefalu, A. B., Giordano, C. S. D. S., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.005 · Cited by 19
Boemi, M., James, R. W., Romagnoli, F., Gerber, P., Pometta, D., & Fumelli, P. (1993) · Diabetologia · doi:10.1007/bf00399955 · Cited by 18
A microtiter plate assay for determining apolipoprotein E genotype and discovery of a rare allele
Livak, K. J., & Hainer, J. W. (1994) · Human Mutation · doi:10.1002/humu.1380030409 · Cited by 18
Apolipoprotein E polymorphism and lipoproteins in insulin-treated diabetes mellitus
Winocour, P. H., Tetlow, L. J., Durrington, P. N., Ishola, M., Hillier, V. F., & Anderson, D. C. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90173-1 · Cited by 18
Exercise Delays Brain Ageing Through Muscle‐Brain Crosstalk
Pourteymour, S., Majhi, R. K., Norheim, F., & Drevon, C. A. (2025) · Cell Proliferation · doi:10.1111/cpr.70026 · Cited by 21
Chen, Y., Lei, K., Liu, Y., Liu, J., Wei, K., Guo, J., & Su, Z. (2025) · Biomolecules · doi:10.3390/biom15070990 · Cited by 20
Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism
Rojas, M. P., Prieto, C., Bermúdez, V., Garicano, C., Nava, T. N., Martínez, M. S., Salazar, J. J., Rojas, E., Pérez, A., Vicuña, P. M., et al. (2018) · F1000Research · doi:10.12688/f1000research.12938.2 · Cited by 17
Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception
Kyriakos, E., Eleni, A., Constantinou, C., Hatziri, A., Kalogeropoulou, C., Xepapadaki, E., & Zvintzou, E. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.32.20180007 · Cited by 17
Gene environment interaction and plasma triglyceride levels: the crucial role of lipoprotein lipase
Hayden, M. R., Liu, M., & Ma, Y. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04197.x · Cited by 17
The allele interaction between apolipoprotein ɛ2 and ɛ4 in Taiwanese Alzheimer's disease patients
Lung, F., Yen, Y., Chou, L. ‐., Hong, C. ‐., & Wu, C. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00394.x · Cited by 17
ROLE OF THE ENTEROHEPATIC CIRCULATION OF BILE SALTS IN LIPOPROTEIN METABOLISM
Cooper, A. D. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70051-0 · Cited by 18
Dilliott, A. A., Sunderland, K. M., McLaughlin, P. M., Roberts, A., Evans, E. C., Abrahão, A., Binns, M. A., Black, S. E., BORRIE, M. J., Casaubon, L. K., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.011 · Cited by 18
Leuthold, A. C., Mahan, M. Y., Stanwyck, J. J., Georgopoulos, A., & Georgopoulos, A. P. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3464-x · Cited by 16
Luc, G., Ducimetière, P., Bard, J., Arveiler, D., Evans, A., Cambien, F., Fruchart, J., & Fiévet, C. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00053-1 · Cited by 16
Apolipoprotein E phenotypes in patients with coronary artery disease.
Miida, T. (1990) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.160.177 · Cited by 16
Pfaffinger, D., Edelstein, C., & Scanu, A. M. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37954-2 · Cited by 16
Ferroptosis: A new strategy for targeting Alzheimer’s disease
Qiang, R. R., Xiang, Y., Zhang, L., Bai, X. Y., Zhang, D., Li, Y. J., Yang, Y. L., & Liu, X. L. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105773 · Cited by 15
Topić, A., Spasojević‐Kalimanovska, V., Zeljković, A., Vekić, J., & Jelić‐Ivanović, Z. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.11.013 · Cited by 15
Hatziri, A., Kalogeropoulou, C. P., Xepapadaki, E., Birli, E., Karavia, E. A., Παπακώστα, Ε., Filou, S., Constantinou, C., & Kypreos, K. E. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.11.007 · Cited by 15
Association of Apo E gene polymorphism with HDL level in Tehranian population
DANESHPOUR, M. S., Hedayati, M., Eshraghi, P., & Azizi, F. (2010) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200900207 · Cited by 15
Peterson, C. K., James, L. M., Anders, S. L., Engdahl, B. E., & Georgopoulos, A. P. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13090205 · Cited by 16
A simple approach for human recombinant apolipoprotein E4 expression and purification
Argyri, L., Skamnaki, V. T., Stratikos, E., & Chroni, A. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.06.011 · Cited by 17
Angelin, B., Holmquist, L., Leijd, B., & Einarsson, K. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb02261.x · Cited by 15
Association of hypercholesterolemia and apolipoprotein E4 in school children
Yanagi, H., Shimakura, Y., Yamanouchi, Y., Watanabe, Y., Tsuchiya, S., & Hamaguchi, H. (1990) · Clinical Genetics · doi:10.1111/j.1399-0004.1990.tb03579.x · Cited by 15
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features
Matsunaga, A., & Saito, T. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65393 · Cited by 14
Lipoproteins and apolipoproteins in human pleural effusions.
Pfalzer, B., Hamm, H., Beisiegel†, U., & Ostendorf, P. (1992) · PubMed · Cited by 14
Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment
Janus, E. D., Grant, S., Lintott, C. J., & Wardell, M. R. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90038-3 · Cited by 15
[40] Intra- and extracellular modifications of apolipoproteins
Zannis, V. I., Karathanasis, S. K., Forbes, G., & Breslow, J. L. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)28100-8 · Cited by 14
Self-citationApoE deficiency: Markedly decreased levels of cellular ApoE mRNA
Anchors, J. M., Gregg, R. E., Law, S. W., & Brewer, H. B. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80510-1 · Cited by 13
Idenitification and characterization of a new variant of apolipoprotein E (apo E-Kochi).
SUEHIRO, T., YOSHIDA, K., YAMANO, T., & OHNO, F. (1990) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.29.587 · Cited by 17
Tremblay, A. J., Lamarche, B., Ruel, I. L., Hogue, J., Deshaies, Y., Gagné, C., & Couture, P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.037 · Cited by 13
Lupattelli, G., Pisciotta, L., VUONO, S. D., Siepi, D., Bellocchio, A., Melis, F., Bertolini, S., Pirro, M., & Mannarino, E. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.12.003 · Cited by 12
Increased Prevalence of Apolipoprotein E3/E4 Genotype among Swedish Renal Transplant Recipients
Roussos, L., Florén, C., Carlson, J. A., Svensson, P. J., Wallmark, A., & Ekberg, H. (1999) · The Nephron journals/Nephron journals · doi:10.1159/000045469 · Cited by 13
The evolution of electrophoretic mobility of proteins
Graur, D. (1986) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(86)80164-3 · Cited by 13
Isoform Patterns of Apolipoprotein E in Diabetes Mellitus
Black, S. C., Hewett, S., Kotubi, Y., Brunt, R. V., & Reckless, J. P. D. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01437.x · Cited by 13
Interaction Between APOE Genotype and Diabetes in Longevity
Shinohara, M., Suzuki, K., Bu, G., & Sato, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210125 · Cited by 12
Neurobiology and the genetics of suicide
Wasserman, D., Marcus, S., Wasserman, J., & Rujescu, D. (2009) · doi:10.1093/med/9780198570059.003.0026 · Cited by 12
Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism
Rojas, M. P., Prieto, C., Bermúdez, V., Garicano, C., Nava, T. N., Martínez, M. S., Salazar, J. J., Rojas, E., Pérez, A., Vicuña, P. M., et al. (2017) · F1000Research · doi:10.12688/f1000research.12938.1 · Cited by 12
Gregg, R. E., Zech, L. A., Gabelli, C., & Brewer, H. B. (1989) · Recent developments in lipid and lipoprotein research · doi:10.1007/978-3-642-83665-7_2 · Cited by 12
Pagnan, A., Busnardo, B., ZANETTI, G., Simioni, N., Braggion, M., Ziron, L., & Girelli, M. E. (1984) · Atherosclerosis · doi:10.1016/0021-9150(84)90022-4 · Cited by 12
Hagiwara, A., Hashimoto, Y., Niikura, T., Ito, Y., Terashita, K., Kita, Y. A., Nishimoto, I., & Umezawa, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3841 · Cited by 12
Molecular cloning and characterization of the promoter region of the porcine apolipoprotein E gene
Xia, J., Hu, B., Mu, Y., Xin, L., Yang, S., & Li, K. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3182-x · Cited by 11
The metabolic basis of familial hypercholesterolaemia
Myant, N. B. (1983) · Journal of Molecular Medicine · doi:10.1007/bf01488153 · Cited by 11
Apolipoprotein E Genotype in Korean Schizophrenic Patients
Lee, M. K., Park, A. J., Nam, B. Y., Min, K. J., Kee, B. S., & Park, D. B. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.6.781 · Cited by 11
Shaw, J. T. E., Tate, J. R., Kasting, J., Marczak, M., Berkholz, J. R., Lovelock, P. K., Purdie, D. M., Hickman, P. E., & Cameron, D. P. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127712.x · Cited by 12
Kempen, H. J. M., Leuven, J. A. G., van der Voort, H. A., de Knijff, P., & Havekes, L. M. (1991) · Metabolism · doi:10.1016/0026-0495(91)90102-3 · Cited by 11
ApoE-2/E-3 ratio of very low density lipoprotein in diabetes mellitus.
SANO, R., Abe, R., Oikawa, S., Fujii, Y., & Toyota, T. (1985) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.146.131 · Cited by 11
Apolipoprotein E Polymorphism in a Healthy Lebanese Population
Almawi, W., Hassan, G., & Habbal, Z. (1999) · Medical Principles and Practice · doi:10.1159/000026078 · Cited by 10
Schizophrenia and Apolipoprotein E Gene Polymorphism in Serbian Population
Kecmanović, M., Dobričić, V. S., Dimitrijević, R., Keckarević, D., Pavicevic, D. S., Marković, M. K., Ivković, M., & Romac, S. P. (2010) · International Journal of Neuroscience · doi:10.3109/00207451003765956 · Cited by 10
Saito, M., Eto, M., & Makino, I. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06026-1 · Cited by 10
Apolipoprotein genes and atherosclerosis
Breslow, J. L. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00235516 · Cited by 10
Self-citationApolipoprotein E Polymorphism in 385 Patients on Renal Replacement Therapy in Sweden
Roussos, L., Ekström, U., Ehle, P. N., Öqvist, B., & Florén, C. (2004) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590410033443 · Cited by 10
Apolipoprotein E phenotypes of normo- and hyperlipoproteinemia in Japanese.
SANO, R., Abe, R., Oikawa, S., FUJII, Y., Hori, S., Suzuki, N., Toyota, T., & Gotō, Y. (1988) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.154.297 · Cited by 10
Smit, M., de Knuff, P., Frants, R. R., Klasen, E. C., & Havekes, L. M. (1987) · Clinical Genetics · doi:10.1111/j.1399-0004.1987.tb03298.x · Cited by 10
ApoE isoforms, treatment of diabetes and the risk of coronary heart disease
Ehara, H. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i3.54 · Cited by 9
Apolipoprotein E: the resilience gene
James, L. M., Engdahl, B. E., & Georgopoulos, A. P. (2017) · Experimental Brain Research · doi:10.1007/s00221-017-4941-4 · Cited by 9
Examination of a nerve injury-induced, 37 kDa protein: Purification and characterization
Ignatius, M. J., Skene, J. H. P., Müller, H. W., & Shooter, E. M. (1987) · Neurochemical Research · doi:10.1007/bf00966320 · Cited by 9
Bennouar, N., Allami, A., Laraqui, A., Azeddoug, H., El-Kadiri, N., Benkouka, F., Bendriss, A., GHANNAM, R., Benomar, A., Fellat, S., et al. (2004) · PubMed · Cited by 9
Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms
James, R. W., Ruiz-Sanz, J. I., Blanché, H., Pometta, D., Passa, P., & Froguel, P. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90030-2 · Cited by 9
Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms
James, R. W., Ruíz, J. G., Blanché, H., Pometta, D., Passa, P., & Froguel, P. (1994) · HAL · Cited by 9
Moriarty, P. M. (2009) · Clinical Lipidology · doi:10.2217/clp.09.21 · Cited by 9
Chen, Q., Wang, T., Kang, D., & Chen, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-18033-x · Cited by 8
Apolipoprotein ε2/3 genotype and type III hyperlipoproteinemia among Taiwanese
Lin, H.-P., & Kao, J. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00050-0 · Cited by 9
Amieva, A. G., López‐Miranda, J., Fuentes, F. J., Castro, P., Marin, C., López‐Granados, A., Vallés, F., & Jiménez, F. P. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00131-5 · Cited by 7
Dong, L.-M., Yamamura, T., Tajima, S., & Yamamoto, A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91321-g · Cited by 8
Apolipoprotein E allele frequencies in a South African Indian female population
Gounden, N., Naidoo, J., Pegoraro, R. J., & Berger, G. M. B. (1995) · Clinical Genetics · doi:10.1111/j.1399-0004.1995.tb04097.x · Cited by 8
Tsuchiya, S., Yamanouchi, Y., Miyazaki, R., Yanagi, H., Yamakawa, K., Yuzawa, K., Ohnuki, M., & Hamaguchi, H. (1987) · The Japanese Journal of Human Genetics · doi:10.1007/bf01910283 · Cited by 8
Rodríguez, A., Calero, O., Veiga, S., Menacho-Román, M., Arribas, I., Cano, L., García-Ribas, G., & Calero, M. (2025) · Alzheimer's Research & Therapy · doi:10.1186/s13195-025-01811-w · Cited by 8
A common 19 bp APOE enhancer deletion is protective against Alzheimer’s disease in African Americans
Brutman, J. N., Busald, T., Nizamis, E., Kaufman, E. J., Lin, E., Hendricks, N. E., Chintamen, S., Sulovari, A., Smukowski, S. N., Ye, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68808-3 · Cited by 7
Dafnis, I., Metso, J., Zannis, V. I., Jauhiainen, M., & Chroni, A. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00681 · Cited by 7
Self-citationPERHAPS: Paired-End short Reads-based HAPlotyping from next-generation Sequencing data
Huang, J., Pallotti, S., Zhou, Q., Kleber, M. E., Xin, X., King, D. A., & Napolioni, V. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa320 · Cited by 7
Potential genetic biomarkers in the early diagnosisof Alzheimer disease: APOE and BIN1
Kaya, G., Gündüz, E., Acar, M., Hatipoğlu, Ö. F., Acar, B., İlhan, A., & Gündüz, M. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1405-96 · Cited by 8
Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative
Dilliott, A. A., Evans, E. C., Farhan, S. M. K., Ghani, M., Sato, C., Zhang, M., McIntyre, A. D., Cao, H., Racacho, L., Robinson, J. F., et al. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2019.228 · Cited by 8
Analytical procedures for the detection and characterization of apolipoprotein E mutants
Assmann, G., Funke, H., & Jabs, H.-U. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90639-9 · Cited by 7
Okada, T., Satô, Y., Iwata, F., Hara, M., Kim, H., & Harada, K. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb01480.x · Cited by 6
Metadata
- Authors
- Zannis, V. I., Breslow, J. L., Utermann, G., Mahley, R. W., Weisgraber, K. H., Havel, R. J., Goldstein, J. L., Brown, M. S., Schonfeld, G., Hazzard, W. R., & Blum, C.
- Affiliations
- Harvard University (US)
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 1982-08
- Volume
- 23
- Issue
- 6
- Pages
- 911-914
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W1770880387
- Cited by
- 436
- References
- 31
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 5 · 2023: 15 · 2022: 8 · 2021: 12 · 2020: 4 · 2019: 4 · 2018: 7 · 2017: 7 · 2016: 9 · 2015: 12 · 2014: 15 · 2013: 11 · 2012: 11
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- apolipoprotein E, APOE genotype, nomenclature, genetic variants, lipoprotein metabolism
- MeSH terms
- Apolipoproteins, Apolipoproteins E, Genotype, Humans, Terminology as Topic, Phenotype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review